These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma. Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas. Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824 [TBL] [Abstract][Full Text] [Related]
5. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim. Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway. Chen T; Gao F; Feng S; Yang T; Chen M Biochem Biophys Res Commun; 2015 Aug; 464(3):748-54. PubMed ID: 26166818 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3. Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455 [TBL] [Abstract][Full Text] [Related]
9. DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells. Jabłońska E; Białopiotrowicz E; Szydłowski M; Prochorec-Sobieszek M; Juszczyński P; Szumera-Ciećkiewicz A Exp Hematol; 2020 Aug; 88():56-67.e2. PubMed ID: 32702393 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92. Morelli E; Biamonte L; Federico C; Amodio N; Di Martino MT; Gallo Cantafio ME; Manzoni M; Scionti F; Samur MK; Gullà A; Stamato MA; Pitari MR; Caracciolo D; Sesti S; Frandsen NM; Rossi M; Neri A; Fulciniti M; Munshi NC; Tagliaferri P; Tassone P Blood; 2018 Sep; 132(10):1050-1063. PubMed ID: 29997223 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression. Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442 [TBL] [Abstract][Full Text] [Related]
12. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice. Sandhu SK; Fassan M; Volinia S; Lovat F; Balatti V; Pekarsky Y; Croce CM Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18208-13. PubMed ID: 24145403 [TBL] [Abstract][Full Text] [Related]
13. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1). Yang F; von Knethen A; Brüne B J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145 [TBL] [Abstract][Full Text] [Related]
15. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing. Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126 [TBL] [Abstract][Full Text] [Related]
16. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma. Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681 [TBL] [Abstract][Full Text] [Related]
17. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma. Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475 [TBL] [Abstract][Full Text] [Related]
18. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11. Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Musilova K; Mraz M Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101. Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]